Creo Medical Ltd – Trademark Portfolio

Entity Type: 99

Creo Medical Ltd holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include CM, KAMAPTIVE, and CREO MEDICAL. The owner is based in Chepstow.

Creo House Unit 2,

Beaufort Park, Beaufort Park Way

Chepstow NP165UH , GB

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Creo Medical Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

11
Environmental Control (2 filings)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does Creo Medical Ltd have?

Creo Medical Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 cancelled.

What trademark classes does Creo Medical Ltd file in?

Creo Medical Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Creo Medical Ltd's most well-known trademarks?

Creo Medical Ltd's registered trademark portfolio includes well-known marks such as CM, KAMAPTIVE, and CREO MEDICAL. These are among 4 currently registered trademarks in the portfolio.

What is Creo Medical Ltd's trademark registration success rate?

Creo Medical Ltd has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.